170 likes | 307 Views
Heart Failure and Qof Quiz. Justin Walker October 2010. Old or New?. Refer patients with suspected heart failure and previous MI urgently, to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks. New!.
E N D
Heart Failure and Qof Quiz Justin Walker October 2010
Old or New? • Refer patients with suspected heart failure and previous MI urgently, to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks.
New! • Refer patients with suspected heart failure and previous MI urgently, to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks.
Old or New? • People with suspected heart failure should initially have a 12 lead ECG and/or BNP to exclude the condition.
Old! • 2010 guidelines suggest echo within 2 weeks if previous MI, BNP if not.
True or False? • Which of the following factors can lower BNP? • Obesity • Diuretics • ACE inhibitors • Tachycardia • PE • Diabetes
True or False? • Which of the following factors can lower BNP? • Obesity True • Diuretics True • ACE inhibitors True • Tachycardia False • PE False • Diabetes False
True or False? • The normal range for BNP is 100-400 pg/mol.
False! • The normal range for BNP is <100 pg/ml • Raised 100-400 pg/ml – Refer within 6 weeks • High >400 pg/ml – Refer within 2 weeks
Beta Blockers • Which of the following are licensed for the treatment of heart failure? • Atenolol • Propanolol • Bisoprolol • Carvedilol • Nebivolol • Labetalol • Sotalol
Beta Blockers • Which of the following are licensed for the treatment of heart failure? • Bisoprolol • Carvedilol • Nebivolol Bisoprolol and carvedilol in any grade of stable heart failure, nebivolol for stable mild to moderate HF.
Angiotensin II Receptor Antagonists • Which of the following are licensed for use in heart failure? • Candesartan • Eprosartan • Irbesartan • Losartan • Valsartan
Angiotensin II Receptor Antagonists • Which of the following are licensed for use in heart failure? • Candesartan • Losartan • Valsartan
Qof Rationale • Heart failure represents the only major cardiovascular disease with increasing prevalence. • Dramatic impairment of quality of life • Poor prognosis • Costly to treat. • Which is the most expensive for the NHS, myocardial infarction, heart failure or stroke?
Ranking • Stroke • Heart failure • Myocardial infarction
Qof Indicators • Register of patients with heart failure • Percentage of patients with HF confirmed by echo or specialist assessment. • Percentage of pts with HF due to LVD on an ACE-i or ARB who can tolerate therapy with no contraindication. • Percentage of pts with HF due to LVD on an ACE-i or ARB additionally treated with a licensed beta-blocker or with recorded intolerance or contraindication. • Points available 4,6,9,10
Qof Indicators • Register of patients with heart failure 4 points • Percentage of patients with HF confirmed by echo or specialist assessment. 6 points • Percentage of pts with HF due to LVD on an ACE-i or ARB who can tolerate therapy with no contraindication. 10 points • Percentage of pts with HF due to LVD on an ACE-i or ARB additionally treated with a licensed beta-blocker or with recorded intolerance or contraindication. 9 points